Ringpu Bio increases stake in Ruihe Bio for ¥2

Tianjin Ringpu Bio-Technology (SZSE:300119) will acquire an additional 15% stake in Tianjin Ruihe Biotechnology for ¥1, increasing its total ownership to 55%. This follows an earlier acquisition of a 40% stake, also for ¥1, in October 2024. The transactions, totaling ¥2, are classified as related party transactions as Ruihe Bio's selling shareholder, Tianjin Ruichuang Bio-Technology, is controlled by Ringpu Bio's chairman. Ringpu Bio will assume the outstanding capital commitment of ¥750 million associated with the 15% stake. The acquisition allows Ringpu Bio to strengthen its synthetic biology portfolio and enhance industrialization efficiency. The company's board has approved the deal, which does not require shareholder approval. Ruihe Bio, which focuses on synthetic biology R&D, will be consolidated into Ringpu Bio's financial statements.